E-LIB Suche - Ergebnisse für: García-Girón, Carlos

1

Molecular Divergence upon EGFR-TKI Resistance Could Be Depe..:

Serna-Blasco, Roberto ; Sánchez-Herrero, Estela ; Robado de Lope, Lucía...
Cancers. 14 (2022) 18 - p. 4446 , 2022

Link: https://doi.org/10.3390/..

2

Analysis of circulating tumour DNA to identify patients wit..:

Provencio, Mariano ; Serna-Blasco, Roberto ; Franco, Fabio...
European Journal of Cancer. 149 (2021) - p. 61-72 , 2021

Link: https://doi.org/10.1016/..

3

Osimertinib in advanced EGFR-T790M mutation-positive non-sm..:

Provencio, Mariano ; Terrasa, Josefa ; Garrido, Pilar...
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

4

Thiosemicarbazone-metal complexes exhibiting cytotoxicity i..:

Alcaraz, Raquel ; Muñiz, Pilar ; Cavia, Mónica...
Journal of Inorganic Biochemistry. 206 (2020) - p. 110993 , 2020

Link: https://doi.org/10.1016/..

5

Oncogenic driver mutations predict outcome in a cohort of h..:

Fernández-Mateos, Javier ; Pérez-García, Jéssica ; Seijas-Tamayo, Raquel...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

6

Revisiting the thiosemicarbazonecopper(II) reaction with gl..:

García-Tojal, Javier ; Gil-García, Rubén ; Fouz, Víctor Ivo...
Journal of Inorganic Biochemistry. 180 (2018) - p. 69-79 , 2018

Link: https://doi.org/10.1016/..

7

Correlation of Hypertension and Proteinuria with Outcome in..:

Feliu, Jaime ; Salud, Antonieta ; Safont, Maria J....
PLOS ONE. 10 (2015) 1 - p. e0116527 , 2015

Link: https://doi.org/10.1371/..

8

Phase II Study of Bevacizumab, Capecitabine, and Oxaliplati..:

Muñoz, Alberto ; Pericay, Carles ; García-Girón, Carlos...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 21 (2014) 4 - p. 181-191 , 2014

Link: https://doi.org/10.3727/..

9

Ensembl 2013:

Flicek, Paul ; Ahmed, Ikhlak ; Amode, M. Ridwan...
Nucleic Acids Research. 41 (2012) D1 - p. D48-D55 , 2012

Link: https://doi.org/10.1093/..

10

A randomized phase II study to compare oxaliplatin plus 5-f..:

Gravalos, Cristina ; Salut, Antonieta ; García-Girón, Carlos...
Clinical and Translational Oncology. 14 (2012) 8 - p. 606-612 , 2012

Link: https://doi.org/10.1007/..

11

Lynch syndrome diagnostics: decision-making process for ger..:

Lastra, Enrique ; García-González, María ; Llorente, Beatriz...
Clinical and Translational Oncology. 14 (2012) 4 - p. 254-262 , 2012

Link: https://doi.org/10.1007/..

12

TAp73 is one of the genes responsible for the lack of respo..:

Herreros-Villanueva, Marta ; Muñiz, Pilar ; García-Girón, Carlos..
Journal of Translational Medicine. 8 (2010) 1 - p. , 2010

Link: https://doi.org/10.1186/..

13

KRAS, BRAF, EGFR and HER2 gene status in a Spanish populati..:

Herreros-Villanueva, Marta ; Rodrigo, Maximiliano ; Claver, Manuel...
Molecular Biology Reports. 38 (2010) 2 - p. 1315-1320 , 2010

Link: https://doi.org/10.1007/..

14

A randomized phase II study of raltitrexed and gefitinib ve..:

Viéitez, José María ; Valladares, Manuel ; Peláez, Ignacio...
Investigational New Drugs. 29 (2010) 5 - p. 1038-1044 , 2010

Link: https://doi.org/10.1007/..

15

PIK3CA mutations in KRAS and BRAF wild type colorectal canc..:

Herreros-Villanueva, Marta ; Gomez-Manero, Noemí ; Muñiz, Pilar..
Molecular Biology Reports. 38 (2010) 2 - p. 1347-1351 , 2010

Link: https://doi.org/10.1007/..